MyFinsight
Home
Blog
About
Contact
Accounts receivable
-$21,623K
Accounts payable
$16,371K
Proceeds from exercise of
stock options
$920K
Stock-based compensation
expense
$15,872K
Depreciation and
amortization
$5,065K
Amortization of debt
discounts
$2,624K
Non-cash operating lease
expense
$1,323K
Other
-$214K
Other assets
-$153K
Net cash provided by
(used in) operating...
$32,876K
Net cash provided by
financing activities
$824K
Canceled cashflow
$30,369K
Canceled cashflow
$96K
Net increase
(decrease) in cash, cash...
$23,348K
Canceled cashflow
$10,352K
Accrued expenses and
other liabilities
-$14,977K
Supplies
$13,328K
Prepaid expenses and
other current assets
$1,554K
Net loss
-$510K
Payment of taxes
withheld from net...
$56K
Payments made on finance
lease obligations
$40K
Net cash used in
investing activities
-$10,342K
Effect of exchange rate
changes on cash, cash...
-$10K
Purchases of property and
equipment
$10,342K
Back
Back
Cash Flow
TN0277-v12_How-To-Order-1(1)
Caris Life Sciences, Inc. (CAI)
TN0277-v12_How-To-Order-1(1)
Caris Life Sciences, Inc. (CAI)
source: myfinsight.com